347 related articles for article (PubMed ID: 6585574)
1. [Central nervous system involvement in adult acute leukemia].
Sasaki H; Maekawa I; Kawamura S; Miyake T
Gan No Rinsho; 1984 Mar; 30(3):221-5. PubMed ID: 6585574
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission.
Singhal S; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Mehta J
Bone Marrow Transplant; 1996 Apr; 17(4):637-41. PubMed ID: 8722368
[TBL] [Abstract][Full Text] [Related]
3. The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement.
Castagnola C; Nozza A; Corso A; Bernasconi C
Haematologica; 1997; 82(5):577-80. PubMed ID: 9407724
[TBL] [Abstract][Full Text] [Related]
4. Effect of the intermittent prophylactic treatment of the central nervous system in adults with acute leukemia.
Kawamura S; Mikami T; Iwamura H; Sawada Y; Yamaya T; Haneda Y; Sakata Y; Chiba Y; Yoshida Y
Biomed Pharmacother; 1987; 41(9-10):462-7. PubMed ID: 3482982
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
6. Failed central nervous system prophylaxis in children with acute lymphoblastic leukaemia: treatment and outcome.
Pinkerton CR; Chessells JM
Br J Haematol; 1984 Aug; 57(4):553-61. PubMed ID: 6589013
[TBL] [Abstract][Full Text] [Related]
7. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
8. CNS prophylaxis using a triple intrathecal drug therapy without cranial irradiation in acute lymphoblastic leukaemia.
Asfour I; Misset JL; Mathe G; Sabbour MS
Int J Clin Pharmacol Res; 1988; 8(1):47-54. PubMed ID: 3163327
[TBL] [Abstract][Full Text] [Related]
9. A preventive therapy of the central nervous system complications in acute leukemias. Preliminary report.
Gingold N; Butoianu E; Nicoară S
Med Interne; 1978; 16(3):291-6. PubMed ID: 279080
[TBL] [Abstract][Full Text] [Related]
10. CNS involvement in leukaemia. An autopsy study of 100 consecutive patients.
Bojsen-Møller M; Nielsen JL
Acta Pathol Microbiol Immunol Scand A; 1983 Jul; 91(4):209-16. PubMed ID: 6575578
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
12. [Extramedullary localization of acute leukemia. I. The involvement of the central nervous system].
Georgieva B; Arnaudov G
Vutr Boles; 1988; 27(1):97-102. PubMed ID: 3166277
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of leukemic infiltrations of the central nervous system. Preliminary communication].
Swencz-Szczepanik K; Kołakowska-Polubiec K; Królikiewicz H; Kaczyńska D; Maj S; Pawelski S
Acta Haematol Pol; 1978; 9(4):257-61. PubMed ID: 282763
[TBL] [Abstract][Full Text] [Related]
14. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate.
Pfeifer H; Wassmann B; Hofmann WK; Komor M; Scheuring U; Brück P; Binckebanck A; Schleyer E; Gökbuget N; Wolff T; Lübbert M; Leimer L; Gschaidmeier H; Hoelzer D; Ottmann OG
Clin Cancer Res; 2003 Oct; 9(13):4674-81. PubMed ID: 14581336
[TBL] [Abstract][Full Text] [Related]
15. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
16. [Effects of prophylactic treatment of central nervous system leukemia in children. Analysis of CNS prophylactic treatment with cyclic high dose multichemotherapy, craniospinal irradiation, and high dose infusion of MTX].
Abe Y; Asakura A; Endo N
Gan To Kagaku Ryoho; 1982 May; 9(5):855-65. PubMed ID: 6964040
[TBL] [Abstract][Full Text] [Related]
17. Failure of late intensification therapy to improve a poor result in childhood lymphoblastic leukemia.
Pui CH; Aur RJ; Bowman WP; Dahl GV; Dodge RK; George SL; Ochs J; Kalwinsky DK; Abromowitch M; Hustu HO
Cancer Res; 1984 Aug; 44(8):3593-8. PubMed ID: 6589042
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
[TBL] [Abstract][Full Text] [Related]
19. Leukemia relapse in long-term survivors of acute leukemia.
Kawashima K; Nagura E; Yamada K; Hamajima N
Cancer; 1985 Jul; 56(1):88-94. PubMed ID: 3859360
[TBL] [Abstract][Full Text] [Related]
20. Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.
Sommer C; Lackner H; Benesch M; Sovinz P; Schwinger W; Moser A; Bergloeff J; Gruber A; Urban C
Ann Hematol; 2008 Nov; 87(11):887-90. PubMed ID: 18575860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
